Study Links Key Gene to Protection from Severe Illness and Death From Covid Infections in Men Under Age 75
Retrieved on:
Wednesday, March 13, 2024
Inflammation, Gene, Brain, Letter, Internal medicine, Rheumatoid arthritis, COVID-19, NYU Langone Health, Infection, Disease, Abramson, Risk, Patient, APG system, Journal, Research, IL1, Factorization of polynomials, Canakinumab, NYU, Death, Doctor of Philosophy, SARS-CoV-2, Attur, Salem, Arthritis, Woman, Male, MPH, National Institutes of Health, IL1RN, Vasopressin receptor 2, Bangladesh Technical Education Board, Fatigue, Blood, Viral, Hospital, Pharmaceutical industry
NEW YORK, March 13, 2024 /PRNewswire/ -- A certain variant of a key anti-inflammatory gene protects men under age 75 from severe illness and death when hospitalized from Covid-19, a genetic analysis of their blood shows.
Key Points:
- NEW YORK, March 13, 2024 /PRNewswire/ -- A certain variant of a key anti-inflammatory gene protects men under age 75 from severe illness and death when hospitalized from Covid-19, a genetic analysis of their blood shows.
- According to the study authors, the protective gene in question, an interleukin-1 receptor antagonist (IL1RN) variant, appears to tamp down inflammation.
- Overall, more men than women (240 men, at 60.5%; and 157 women, at 39.5%) died from their disease, with women 20% less likely to die than men.
- Funding support for this study was provided by National Institutes of Health grants P30CA016087 and R21AR078466.